Anuh Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Anuh Pharma has a total shareholder equity of ₹2.6B and total debt of ₹82.0M, which brings its debt-to-equity ratio to 3.2%. Its total assets and total liabilities are ₹4.0B and ₹1.4B respectively. Anuh Pharma's EBIT is ₹635.4M making its interest coverage ratio -52. It has cash and short-term investments of ₹565.4M.
Key information
3.2%
Debt to equity ratio
₹82.03m
Debt
Interest coverage ratio | -52x |
Cash | ₹565.39m |
Equity | ₹2.57b |
Total liabilities | ₹1.43b |
Total assets | ₹4.00b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 506260's short term assets (₹2.9B) exceed its short term liabilities (₹1.4B).
Long Term Liabilities: 506260's short term assets (₹2.9B) exceed its long term liabilities (₹21.0M).
Debt to Equity History and Analysis
Debt Level: 506260 has more cash than its total debt.
Reducing Debt: 506260's debt to equity ratio has increased from 1.9% to 3.2% over the past 5 years.
Debt Coverage: 506260's debt is well covered by operating cash flow (181.4%).
Interest Coverage: 506260 earns more interest than it pays, so coverage of interest payments is not a concern.